AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2017
Nov 13, 2017
32870_dirs_2017-11-13_97606933-12c3-408f-879b-b62a693681eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-11-08
Reporting Person: Zoon Kathryn C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-08 | Common Stock | S | 2371 | $38.9443 | Disposed | 20114 | Direct |
| 2017-11-08 | Common Stock | S | 371 | $40.8446 | Disposed | 19743 | Direct |
Footnotes
F1: Consists of restricted stock units granted under the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
F2: The restricted stock units vest in three equal annual tranches beginning in November 2017.
F3: The transactions reported in this row were effected pursuant to a Rule 10b5-1 plan adopted by Dr. Zoon.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.25, inclusive.
F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.84 to $40.85, inclusive.